352 related articles for article (PubMed ID: 15700117)
1. Decrease in circulating endothelial cell adhesion molecule and thrombomodulin levels during oral iloprost treatment in rheumatoid arthritis patients: preliminary results.
Boehme MW; Gao IK; Norden C; Lemmel EM
Rheumatol Int; 2006 Feb; 26(4):340-7. PubMed ID: 15700117
[TBL] [Abstract][Full Text] [Related]
2. Systemic sclerosis-related Raynaud's phenomenon: effects of iloprost infusion therapy on serum cytokine, growth factor and soluble adhesion molecule levels.
Mittag M; Beckheinrich P; Haustein UF
Acta Derm Venereol; 2001; 81(4):294-7. PubMed ID: 11720181
[TBL] [Abstract][Full Text] [Related]
3. Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis.
Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
Scand J Rheumatol; 2009; 38(6):439-44. PubMed ID: 19922018
[TBL] [Abstract][Full Text] [Related]
4. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease.
Tsakiris DA; Tschöpl M; Jäger K; Haefeli WE; Wolf F; Marbet GA
Atherosclerosis; 1999 Jan; 142(1):193-200. PubMed ID: 9920521
[TBL] [Abstract][Full Text] [Related]
5. A 7-day oral treatment of patients with active rheumatoid arthritis using the prostacyclin analog iloprost: cytokine modulation, safety, and clinical effects.
Gao IK; Scholz P; Boehme MW; Norden C; Lemmel EM
Rheumatol Int; 2002 Jun; 22(2):45-51. PubMed ID: 12070674
[TBL] [Abstract][Full Text] [Related]
6. Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis.
Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
Ann Rheum Dis; 2002 Sep; 61(9):804-9. PubMed ID: 12176805
[TBL] [Abstract][Full Text] [Related]
7. A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis.
Littler AJ; Buckley CD; Wordsworth P; Collins I; Martinson J; Simmons DL
Br J Rheumatol; 1997 Feb; 36(2):164-9. PubMed ID: 9133922
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of thrombomodulin, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in the acute phase of Plasmodium vivax malaria.
Ohnishi K
Am J Trop Med Hyg; 1999 Feb; 60(2):248-50. PubMed ID: 10072144
[TBL] [Abstract][Full Text] [Related]
9. Reduction of soluble adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor levels in serum of rheumatoid arthritis patients following multiple intravenous infusions of infliximab.
Klimiuk PA; Sierakowski S; Domysławska I; Fiedorczyk M; Chwiećko J
Arch Immunol Ther Exp (Warsz); 2004; 52(1):36-42. PubMed ID: 15053231
[TBL] [Abstract][Full Text] [Related]
10. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin.
Peter K; Nawroth P; Conradt C; Nordt T; Weiss T; Boehme M; Wunsch A; Allenberg J; Kübler W; Bode C
Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):505-12. PubMed ID: 9102169
[TBL] [Abstract][Full Text] [Related]
11. Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis.
Klimiuk PA; Fiedorczyk M; Sierakowski S; Chwiecko J
Scand J Rheumatol; 2007; 36(5):345-50. PubMed ID: 17963163
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of rheumatoid arthritis is associated with a reduction in serum sE-selectin and thrombomodulin level.
Cobankara V; Ozatli D; Kiraz S; Oztürk MA; Ertenli I; Türk T; Apras S; Haznedaroglu IC; Calgüneri M
Clin Rheumatol; 2004 Oct; 23(5):430-4. PubMed ID: 15278755
[TBL] [Abstract][Full Text] [Related]
13. Interaction of endothelial cells and neutrophils in vitro: kinetics of thrombomodulin, intercellular adhesion molecule-1 (ICAM-1), E-selectin, and vascular cell adhesion molecule-1 (VCAM-1): implications for the relevance as serological disease activity markers in vasculitides.
Boehme MW; Raeth U; Scherbaum WA; Galle PR; Stremmel W
Clin Exp Immunol; 2000 Jan; 119(1):250-4. PubMed ID: 10606990
[TBL] [Abstract][Full Text] [Related]
14. The effects of dipyridamole stress test on plasma levels of soluble adhesion molecules intracellular adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin and L-selectin in patients with ischemic heart disease and patients with syndrome X.
Siminiak T; Smielecki J; Rzeźniczak J; Kaźmierczak M; Kalawski R; Wysocki H
Coron Artery Dis; 1999 Jun; 10(4):235-40. PubMed ID: 10376202
[TBL] [Abstract][Full Text] [Related]
15. Prostacyclin analogue iloprost influences endothelial cell-associated soluble adhesion molecules and growth factors in patients with systemic sclerosis: a time course study of serum concentrations.
Rehberger P; Beckheinrich-Mrowka P; Haustein UF; Sticherling M
Acta Derm Venereol; 2009; 89(3):245-9. PubMed ID: 19479119
[TBL] [Abstract][Full Text] [Related]
16. Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis.
Denton CP; Bickerstaff MC; Shiwen X; Carulli MT; Haskard DO; Dubois RM; Black CM
Br J Rheumatol; 1995 Nov; 34(11):1048-54. PubMed ID: 8542206
[TBL] [Abstract][Full Text] [Related]
17. Suppression of circulating interleukin-6 concentrations is associated with decreased endothelial activation in rheumatoid arthritis.
Dessein PH; Joffe BI
Clin Exp Rheumatol; 2006; 24(2):161-7. PubMed ID: 16762151
[TBL] [Abstract][Full Text] [Related]
18. [Soluble cell adhesion molecules in chronic renal graft rejection].
Boratyńska M
Pol Arch Med Wewn; 1998 Nov; 100(5):410-8. PubMed ID: 10410574
[TBL] [Abstract][Full Text] [Related]
19. Soluble adhesion molecules in juvenile rheumatoid arthritis.
Bloom BJ; Miller LC; Tucker LB; Schaller JG; Blier PR
J Rheumatol; 1999 Sep; 26(9):2044-8. PubMed ID: 10493690
[TBL] [Abstract][Full Text] [Related]
20. Serum thrombomodulin-a reliable marker of disease activity in systemic lupus erythematosus (SLE): advantage over established serological parameters to indicate disease activity.
Boehme MW; Raeth U; Galle PR; Stremmel W; Scherbaum WA
Clin Exp Immunol; 2000 Jan; 119(1):189-95. PubMed ID: 10606982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
